NCT01211808View on ClinicalTrials.gov

Effect of Diltiazem on Pharmacokinetics of BMS-914392

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Atrial Fibrillation
Interventions
DRUG

BMS-914832

Tablets, Oral, 30 mg, once, 1 day

DRUG

Diltiazem

Tablets, Oral, 360 mg, once daily, 10 days

Trial Locations (1)

66219

Pra International, Lenexa

Sponsors

Collaborators (1)

PRA Health Sciences
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY